ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon +6 more
wiley +1 more source
Granulocyte colony-stimulating factor-producing lung cancer complicated with antiphospholipid antibody syndrome: a case report. [PDF]
Yoshino R +5 more
europepmc +1 more source
Granulocyte Colony-Stimulating Factor Prevents Reperfusion Injury after Heart Preservation [PDF]
ヒグチ, タクヤ, 樋口, 卓也
core
The impact of delayed versus early administration of granulocyte colony-stimulating factor following autologous hematopoietic stem cell transplantation on transplantation outcome. [PDF]
Mahdizadeh M +4 more
europepmc +1 more source
Granulocyte-colony stimulating factor use in alcohol-associated hepatitis: is it time to promote liver regeneration? [PDF]
Díaz LA, Arab JP, Leggio L.
europepmc +1 more source
Differentiation of the mononuclear phagocyte system during mouse embryogenesis:the role of transcription factor PU.1 [PDF]
Browne, C M +7 more
core
Optimizing Granulocyte-Colony Stimulating Factor Dosing Scheme in Healthy Stem Cell Donors for Allogenic Transplantation: A Retrospective Cohort Study of Single Dose vs. Split Dose. [PDF]
Özkan SG +8 more
europepmc +1 more source
The Role of Combined Treatment of Granulocyte Colony-stimulating Factor and Oestrogen in Treatment of Thin Endometrium: A Rat Model. [PDF]
Kahyaoglu I +3 more
europepmc +1 more source
Daratumumab improved severe neutrophilia and paraneoplastic bone marrow fibrosis in granulocyte-colony stimulating factor-producing multiple myeloma. [PDF]
Sakamoto M +8 more
europepmc +1 more source

